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Regulation of Human Umbilical Artery Contractility By Different
Serotonin and Histamine Receptors
António José Santos-Silva, MD, Elisa Cairrão, MSc, Bruno Marques, MSc, and
Ignacio Verde, PhD
We studied the role of several serotonin (5-HT) and histamine receptors in the regulation of human
umbilical artery (HUA) contractility. Among the 5-HT agonists used, only the 5-HT2A and 5-
HT1B/D agonists contracts HUA. The 5-HT-induced contractions were fully inhibited by ketanserin
(5-HT2A antagonist). The 5-HT7-activation also relaxes and increases intracellular cyclic adenosine
monophosphate (cAMP). Among the histamine receptor agonists, only betahistine (H1 agonist)
induced significant contractile effect. Histamine-induced contraction was partially relaxed by pyrila-
mine (H1 antagonist). Betahistine-induced contraction was partially blocked by dimaprit (H2 agonist)
and by the H3 agonist when a low concentration of forskolin is present. Both, H2 and H3 agonists
increased the cAMP intracellular levels in HUA smooth muscle. These findings show that in HUA,
5-HT2A- and 5-HT1B/1D-activation lead to vasoconstriction and 5-HT7-activation induces vasorelaxa-
tion. Concerning histamine receptors, H1-activation induces contraction and H2- and H3-activation lead to
vasorelaxation.
KEY WORDS: Umbilical cord, histamine, 5-HT, human, vascular smooth muscle, cyclic
AMP.
INTRODUCTION
The mechanisms that regulate the contractile state of
the smooth muscle cells in the human umbilical artery
(HUA) are very important for optimum gas and
nutrient exchange between the fetus and the placenta.
Because the umbilical blood vessels are not innervated,
the control of umbilical blood flow depends on vasoactive
substances either released locally or existing in the circu-
lation,1,2 such as serotonin (5-HT; 5-hydroxytryptamine)
and histamine. As previously reported, 5-HT1-3and hista-
mine4 induce significant contractions of HUA. The
5-HT-induced contractions appear to be higher than those
induced by histamine.5,6 The basal concentrations of these
2 substances in the umbilical artery blood of normal preg-
nant women during gestation are around 50 ng/mL
for histamine and 5 ng/mL for 5-HT.7,8 However,
several authors described that preeclampsia is associated
with increase in histamine and 5-HT release and in the
sensitivity of the HUA to these mediators, which can
lead to increase of vascular resistance.9-12 Thus, 5-HT and
histamine can regulate the HUA tone and are involved
in some pathological processes that disturb umbilical
circulation.
5-HT is a biogenic monoamine which mediates
the smooth muscle contractility through the activation
of different receptors (5-HT1 to 5-HT7).
13 Among them,
5-HT1B, 5-HT1D, 5-HT2A, 5-HT2B, 5-HT4, and 5-HT7
receptors were shown to be expressed in blood vessels,
even if messenger (mRNA) for 5-HT2B and 5-HT4 were
only found in human endothelial cells.14 The 5-HT1B
and 5-HT1D receptors are coupled to Gi/Go protein,
which inhibits adenylate cyclase. The 5-HT2A receptor
is positively coupled to Gq protein. The 5-HT7 receptor
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(EC).
Address correspondence to: Ignacio Verde, PhD, Centro de Investigação em
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is coupled to Gs, which stimulates adenylate cyclase.
15,16
Some studies on HUA revealed that the contractility
induced by 5-HT involves 5-HT1B, 5-HT1D, and
5-HT2A receptors.
3,12 Lovren et al showed that 5-HT1B
and 5-HT2A receptors are expressed in HUA, but they did
not find expression of 5-HT1D receptors in this artery.
17 In
addition, recent data showed that the 5-HT7 receptors
mediate endothelium-independent relaxation of pig
pulmonary artery.18 Despite these data, the role of these
receptors in the regulation of HUA is still unclear.
Histamine is also a vasoactive substance that can acti-
vate different receptors (H1 to H4).
19 In general, H1
receptor couples to the Gq and causes mobilization of
intracellular calcium.20 The H2 receptor causes cyclic
adenosine monophosphate (cAMP) accumulation due
to Gs activation.
20 The H3 receptor could be positively
coupled to a Gi/Go, although the intracellular signal
transduction pathway initiated by the activation of this
receptor is still under debate.20-22 However, it was
demonstrated that the H3 activation elicited a vasodilator
response on some arteries,23,24 data that are contradictory
with a decrease of cAMP intracellular levels. Concerning
the H4 receptor, it could be functionally coupled to
Gi/Go protein, causing either mobilization of intracellular
calcium or inhibition of adenylate cyclase activity.25
Histamine can induce contractility or relaxation depend-
ing on the expression and/or participation of different
types of histamine receptors in each specific vascular
vessel.13,26-28
In the current study, we studied the presence of
different subtypes of 5-HT and histamine receptors and
their functional role in the HUA tone regulation by
using pharmacological, biochemical, and molecular
approaches. Firstly, we examined the presence of
mRNAs encoding different types of 5-HT and histamine
receptors. Secondly, we examined the effects of different
agonists and antagonists of different 5-HT and histamine
receptors on the vasomotor tone. Also, to asses the adeny-
late cyclase regulation by some agonists of these receptors,




Umbilical cord pieces of 3 to 7 cm, from the extremity
closer to the newborn’s (20 cm), were obtained from nor-
mal term pregnancies after vaginal delivery, with the
consent of the donor mothers. All the procedures carried
out using the umbilical cords were approved by the Ethics
Committee of ‘‘Centro Hospitalar da Cova da Beira
EPE.’’ In total, 113 umbilical cord samples were collected
in sterile physiological saline solution (PSS; composition,
mmol/L: NaCl 110; CaCl2 0.15; KCl 5; MgCl2 2;
HEPES 10; NaHCO3 10; KH2PO4 0.5; NaH2PO4 0.5;
Glucose 10; EDTA 0.49). To avoid contamination and
tissue degradation, penicillin (5 U/mL), streptomycin
(5 mg/mL), amphotericin B (12.5 ng/mL), and antipro-
teases (leupeptine 0.45 mg/L, benzamidine 26 mg/L,
and trypsin inhibitor 10 mg/L) were added to the PSS
solution. Umbilical artery rings of 3 to 5 mm were iso-
lated from the surrounding connective tissue. Vascular
endothelium was mechanically removed by gentle rub-
bing with a cotton bud introduced through the arterial
lumen. These denuded HUA rings were used to perform
contractility experiments. Some HUA rings were
chopped to rectangle pieces using scissors, and smooth
muscle layers from the tunica media were extracted using
surgical forceps and scalpel. The reverse transcriptase
polymerase chain reaction (RT-PCR) and the cAMP
radioimmunoassay experiments were performed using
these tunica media layers.
Analysis of the Expression of Histamine and
5-HT Receptors by RT-PCR
Reverse transcriptase–polymerase chain reaction by using
primers against the different 5-HT and histamine recep-
tors subtypes was used to analyze their expression. The
human housekeeping gene glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) was used to assess relative
quantities of DNA from each sample. Total RNA was
prepared from smooth muscle layers of human umbilical
artery using the Tri reagent RNA purification system
(Sigma, Saint Louis, Missouri). The complementary
DNA (cDNA) was prepared from mRNA with random
primers (3 mg/mL) using II RNAase H-reverse transcrip-
tase and the conditions recommended by the manufac-
turer (10 U/mL). Five ng of cDNA were amplified in
25 mL reaction mixture containing 200 mmol/L deoxyr-
ibonucleotide triphosphate (dNTPs), 0.625 U of
Taq-polymerase, and 25 pmol/mL of primers in buffer
supplied by the manufacturer (Promega, Madison,
Wisconsin). Oligonucleotide primers designed were as
indicated in Table 1.
The PCR procedures were performed as follows: 35
cycles (30 seconds at 94C, 30 seconds at 55C-60C, and
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30 seconds at 72C) and a final elongation (5 minutes at
72C). The PCR products were separated by electro-
phoresis on 1.5% agarose gel containing 0.01% of ethi-
dium bromide and photographed under UV irradiation
(320 nm).
Artery Tension Recording
The human umbilical artery rings were placed in organ
bath (LE01.004, Letica) chambers containing Krebs-
bicarbonate solution (composition, mmol/L: NaCl 119,
KCl 5.0, NaHCO3 25, KH2PO4 1.2, CaCl2 0.5, MgSO4
1.2, EDTA 0.03, glucose 11) at 37C and continuously
gassed with carbogen. The artery rings were suspended
between 2 parallel stainless steel wires and tension mea-
surement in grams (g) was performed using isometric
transducers (TRI201, Panlab SA, Spain), amplifier
(ML118/D Quad Bridge, ADInstruments), interface
PowerLab/4SP (ML750, ADInstruments), and compu-
terized system with Chart5 PowerLab software (ADIn-
struments). For analysis, the isometric tension measured
was expressed in milligrams (mg) of force elicited by the
artery in presence of drugs. To analyze the relaxation
data, we used the percentage of reduction on the maximal
contraction induced by the contractile agents. During the
resting periods, the organ bath solution was changed
every 15 minutes. Initially, the rings were equilibrated for
60 minutes until a resting tension of 1 gram was achieved.
This resting tension was previously used by other authors
working with HUA29,30 and is supposed to be equivalent
to 100 mm Hg in the artery. After this, the rings were
challenged with a supramaximal concentration of 5-HT
(1 mmol/L) to test their viability. Rings that induced a
maximal contraction lower than 1 gram when challenged
with 5-HT were excluded from the study. To determine
the involvement of distinct types of 5-HT and histamine
receptors in the regulation of the vascular contractility
supramaximal concentration of the following agonists and
antagonists of these receptors were used12,31: 5-hydroxy-
tryptamine (5-HT; 1 mmol/L), unspecific agonist of
5-HT receptors; L-694,247 (L69; 1 mmol/L), agonist of
5-HT1B and 5-HT1D receptors; alpha-methyl-5-hydro-
xytryptamine (AMHT; 1 mmol/L), agonist of 5-HT2A
receptors; ketanserin (10 mmol/L), antagonist of 5HT2A
receptors; AS19 (1 mmol/L), agonist of 5-HT7 receptors;
histamine (1 mmol/L), unspecific agonist of histamine
receptors; betahistine (1 mmol/L), agonist of H1 recep-
tors; pyrilamine (100 mmol/L), antagonist of H1 recep-
tors; dimaprit (100 mmol/L), agonist of H2 receptors;
cimetidine (10 mmol/L), antagonist of H2 receptor;
(R)-(–)-alpha-methylhistamine (RMH; 0.1 mmol/L),
agonist of H3 receptors; 4-methylhistamine (4-MH;
0.1 mmol/L), agonist H4 receptors.
To further analyze the involvement of the cAMP
pathway after the activation of some receptors, rolipram
(1 mmol/L), a phosphodiesterase 4 (PDE4) specific inhi-
bitor, or forskolin (0.1 or 10 mmol/L), an adenylate
cyclase activator,5 were used in some cases.
Control experiments with ethanol, the vehicle used
to dissolve some drugs, were always performed.
Cyclic AMP radioimmunoassay
The HUA smooth muscle layers were weighted and incu-
bated at 37C for 30 minutes in Krebs solution with or
without drugs. Afterward, the tissue samples were prepared
according to the instructions provided by the manufacturer
(cAMP EIA Kit, Cayman Chemical, Montluçon, France).
Briefly, the layers were rapidly frozen using liquid nitro-
gen, homogenized in 500 mL of 5% trichloroacetic acid
(TCA). After homogenization, the extract was centrifuged,
for 10 minutes at 1500g and 4C. Trichloroacetic acid was
Table 1. Oligonucleotide Primers Designed to Analyze the Expression of Histamine (H1 to H4) and 5-HT (5-HT1B, 5-HT1D,
5-HT2A, and 5-HT7) Receptors and Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH)
Receptor Genbank Number Forward Primer Reverse Primer Fragment Size (bp)
5-HT1B NM000863 5















GAPDH MN002046 50-cgccagcccgagccacatc-30 50-cgcccaatacgaccaaatccg-30 75
Regulation of Human Umbilical Artery Contractility Reproductive Sciences Vol. 16, No. 12, December 2009 1177
 at HINARI on December 23, 2009 http://rsx.sagepub.comDownloaded from 
extracted from the samples using water-saturated ether and
finally the ether was eliminated by heating. The aqueous
supernatant obtained was used for the cAMP assay accord-
ing to the instructions provided by the manufacturer.
Control experiments with ethanol, the vehicle used
to dissolve some drugs, were always performed.
Drugs and Chemicals
All drugs and chemicals were purchased from Sigma-
Aldrich Quimica (Sintra, Portugal), except forskolin, roli-
pram, dimaprit, RMH, 4-MH, L69, AMHT, and AS19,
which were purchased from Biogen Cientifica (Madrid,
Spain). Forskolin, rolipram, betahistine, RMH, L69, and
AS19, were initially dissolved in ethanol, and final solu-
tions were obtained by dilution with Krebs solution. The
final concentration of ethanol in the organ bath did not
exceed 0.1%. All the other drugs were initially dissolved
in distilled water and final solutions were obtained by
dilution with Krebs solution.
Statistical Analysis
Statistical treatment of data was performed using the Sig-
maStat Statistical Analysis System, version 1.00 (1992).
Results are expressed as mean + SEM of n experiments.
Comparison among multiple groups was analyzed by using
a one-way ANOVA followed by Tukey post hoc test to
determine significant differences among the means. Multi-
ple comparison between 2 groups was analyzed by using
ANOVA followed by Dunnet’s post hoc test. Probability
levels lower than 5% were considered significant (P < .05).
RESULTS
Analysis of the Expression of Different
5-HT and Histamine Receptors
Semi-quantitative RT-PCR analysis with specific primers
was performed using HUA smooth muscle layers to check
for the expression of 5-HT1B, 5-HT1D, 5-HT2A, 5-HT7,
H1, H2, H3, and H4 receptors. Positive controls were per-
formed using glyceraldehyde 3-phosphate dehydrogenase
primers (GAPDH) (Figure 1). Negative control experi-
ments to confirm the absence of cDNA contamination
from endothelial cells and fibroblast were performed with
primers against Von Willibrand Factor and ICAM-1 and
were always negative (data not shown). Also, negative con-
trols to confirm the absence of DNA contamination during
the experiences were performed in the absence of HUA
smooth muscle cDNA (Figure 1).
Human umbilical artery smooth muscle expresses
significant amounts of the following receptors: 5-HT1B,
5-HT1D, 5-HT2A, 5-HT7, H1, H2, H3, and H4 (Figure
1). Concerning the level of expression of 5-HT receptors,
the rank order is 5-HT1B > 5-HT1D  5-HT7 > 5-
HT2A. For the histamine receptors, the rank order is H1
> H3  H4 > H2. The expression of these receptors was
detected in smooth muscle layers from 5 different HUA.
Effects of Agonists and Antagonists of
Different 5-HT Receptors on Contractility
In the contractility experiments, the rings were placed in
Krebs-bicarbonate solution with 0.5 mmol/L CaCl2. In
Figure 1. Expression analysis of different 5-HT and histamine receptors. Reverse transcriptase–polymerase chain reaction (RT-PCR) analysis
was performed as described in the Material & Methods section. Negative controls (N) were performed in absence of messenger (mRNA) in
contrast with that realized in presence (P) of mRNA from human umbilical artery (HUA) smooth muscle layers. The PCR products were
analyzed on a 1.5% agarose gel and pictures of the ethidium bromide stained gels are shown. A, Positive control using glyceraldehyde
3-phosphate dehydrogenase primers (G) and expression of 5-HT1B, 5-HT1D, negative 5-HT1D, 5-HT2A, and 5-HT7 receptors. B, Expression
of H1, H2, H3, and H4 receptors. Positions of molecular weight markers (MA) are indicated in base pairs (bp).
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fact, in the first experiments (data not shown), we
used 1.5 mmol/L of CaCl2 and a consistent number of
HUA rings did not contract in response to 5-HT or
KCl. Several authors, using concentrations of CaCl2
up of 1 mmol/L, already experienced the same phe-
nomenon.1,4,32 After testing several concentrations, we
observed that, in contrast with upper concentrations,
we always obtained consistent contractile effects using
0.5 mmol/L of CaCl2 in the Krebs solution. However,
we also observed that the maximal contractile effect using
this CaCl2 concentration was not decreased in contrast
with upper concentrations (data not shown). In agree-
ment with this, Okatani et al measured the contractile
effect induced by CaCl2 in depolarizing medium and
showed that 0.5 mmol/L of CaCl2 induces similar con-
traction than 1 mmol/L.33
Human umbilical artery rings without endothelium
were contracted by 5-HT (1 mmol/L) and stable contrac-
tions were attained after 5 to 10 minutes (1690.2 + 67.0
mg). The involvement of different 5-HT receptors on
this effect was analyzed using specific agonists and antago-
nists of these receptors.
As shown in Figure 2, the 5-HT2A agonist (AMHT;
1 mmol/L) induced a contractile response that is similar to
that induced by 5-HT (P > .05). However, ketanserin
(10 mmol/L), a 5-HT2A antagonist, significantly relaxed
(88.2% + 6.6%; n ¼ 10) the rings contracted by 5-HT
(P < .05). These data indicate that the major reason for
the 5-HT effect is the activation of 5-HT2A receptors.
Nevertheless, L69 (1 mmol/L), an agonist of the 5-HT1B
and 5-HT1D receptors, also induced contraction (352.8
+ 64.6 mg). However, we also observed that L69 did not
induce the same contractile effect in all the HUA rings. As
shown in the Figure 2, there are 3 bars to represent the
effect of this agonist. The second bar represents the media
of the contractile effect induced by L69 (39 arteries).
From these 39 arteries, in 9 HUA (first bar; 969.7 +
143.1 mg) the contractile effect was huge when compared
with the media (middle bar; 352.8 + 64.6 mg). The
effect represented in the third bar corresponds to the
other 30 arteries (167.7 + 22.9 mg), in which the effect
is not significantly different from the media (Figure 2).
Thus, these data suggest that 5-HT1B/1D receptors can
also participate in the 5-HT contractile effect, but there
is variability in the response of this agonist in different
HUA.
The involvement of 5-HT7 receptor was also inves-
tigated. As this receptor was shown to be coupled to ade-
nylate cyclase, we performed relaxing experiments on
HUA contracted by a 5-HT2A agonist (AMHT,
1 mmol/L). The 5-HT7 agonist (AS19, 1 mmol/L)
weakly relaxed the artery rings contracted by AMHT.
This effect is similar to that obtained by adenylate cyclase
stimulation with a supramaximal concentration of forsko-
lin (10 mmol/L). As expected, the forskolin effect is
increased when PDE4 is inhibited by rolipram
(1 mmol/L). However, the relaxant effect induced by
AS19 was not significantly increased in presence of roli-
pram (Figure 3). Figure 4A shows a record of an experi-
ment in which AMTH-contracted arteries were relaxed
by forskolin (10 mmol/L) and this effect is increased when
rolipram (1 mmol/L) is further added.
Ethanol, the vehicle used to dissolve forskolin, roli-
pram, and AS19, did not have a significant relaxant effect
at the concentrations used (data not shown).
Effects of Agonists and Antagonists of
Different Histamine Receptors on
Contractility
Human umbilical artery rings without endothelium were
contracted by a supramaximal concentration of histamine
(1 mmol/L) and stable contractions were attained after 5
to 10 minutes (863.8 + 52.1 mg). The involvement of
different histamine receptors on this effect was analyzed
using specific agonists and antagonists of these receptors.
Figure 2. Contractile effect of 5-HT receptor agonists. Contrac-
tions (mg) induced by 5-HT (1 mmol/L), L69 (5-HT1B/D agonist;
1 mmol/L), and alpha-methyl-5-hydroxytryptamine (AMHT; 5-
HT2A agonist; 1 mmol/L). The dual effect of L69 is indicated by 3
bars representing the high (left) and low (right) effects and the total
effect (middle). The bars represent the mean and the lines the SEM of
the number of experiments indicated near the bar. Different letters
indicated significant differences and when bars do not share the same
letter this means that there are significant differences (P < .05, one-
way ANOVA with Tukey post hoc test) between the effects.
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Among the histamine receptor agonists used, exclud-
ing histamine, only a supramaximal concentration of the
H1-receptor agonist betahistine (1 mmol/L) induced a
significant contractile effect (Figure 5), which is higher
than the contractile effect induced by histamine itself
(P < .05). However, the histamine-induced contraction
was almost completely relaxed (97.2% + 0.1%, n ¼ 8)
by pyrilamine (100 mmol/L), a H1 antagonist. These data
indicate that the major reason for the histamine effect is
the activation of this receptor. However, the effect of
betahistine is bigger than that of histamine, suggesting
either that histamine is less selective for the H1 receptor
or that histamine effect is the consequence of the activa-
tion of different receptors that signal to induce contrac-
tion and relaxation at the same time, resulting in a
lower contractile effect.
The H2 receptor agonist dimaprit (100 mmol/L) did
not induce contraction of HUA (Figure 5). To investigate
a possible relaxant effect induced by the activation of H2
receptor, the action of dimaprit on rings contracted by an
agonist H1 (betahistine; 1 mmol/L) was analyzed. Dima-
prit (100 mmol/L) partially relaxed (25.3% + 2.0%, n ¼
9) the contraction induced by betahistine. However, the
effect of histamine was not significantly increased by the
presence of the H2-receptor antagonist cimetidine
(10 mmol/L). However, the effect of these 2 drugs
applied in combination was not significantly different
than that induced by the H1 agonist BHI (Figure 5).
The involvement of H3 and H4 receptors was also
investigated using RMH and 4-MH, agonists for H3 and
H4 receptors, respectively. These agonists did not induce
any contractile effect in HUA (Figure 5). When applied
alone, RMH or 4-MH does not significantly relax con-
traction induced by the betahistine (Figure 6). As a supra-
maximal concentration of forskolin (10 mmol/L) elicited
almost 100% of relaxation on betahistine-induced con-
tractions (data not shown), we used a lower concentration
(0.1 mmol/L), which relaxed around 40%, to analyze if
the agonists of H3 and H4 receptors increased this effect.
The presence of RMH significantly increased the forsko-
lin (0.1 mmol/L) effect on betahistine contracted arteries
Figure 3. Relaxant effects of the 5-HT7 receptor activation and
adenylate cyclase activation. The arteries were contracted by alpha-
methyl-5-hydroxytryptamine (AMHT; 5-HT2A agonist; 1 mmol/L)
and the percentage of relaxation of AS19 (5-HT7 agonist; 1 mmol/L)
and forskolin (FSK, adenylate cyclase activator; 10 mmol/L) in
absence and presence of rolipram (ROL, phosphodiesterase 4
inhibitor; 1 mmol/L) is indicated. The bars represent the mean and
the lines the SEM of the number of experiments indicated near the
bar. Different letters indicated significant differences and when bars do
not share the same letter this means that there are significant
differences (P < .05, one-way ANOVA with Tukey post hoc test)
between the effects.
Figure 4. Original record of 2 tension experiments with human
umbilical artery rings. A, The artery rings were contracted by alpha-
methyl-5-hydroxytryptamine (AMTH; 1 mmol/L) and relaxed by
forskolin (10 mmol/L) alone and in presence of rolipram (1 mmol/L);
B, The artery rings were contracted by betahistine (1 mmol/L) and
relaxed by (R)-(-)-alpha-methylhistamine (RMH; 0.1 mmol/L) alone
and in presence of forskolin (0.1 mmol/L).
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(Figure 6), suggesting that the H3 receptors can induce
relaxant effects through the cAMP pathway when the
basal levels of this cyclic nucleotide are partially increased.
However 4-MH did not increase the forskolin relaxant
effect (Figure 6). Figure 4B shows a record of an experi-
ment in which betahistine-contracted arteries were
almost unaffected by RMH and this effect was increased
when forskolin (0.1 mmol/L) was further added. How-
ever, the presence of 4-MH did not change the forskolin
(0.1 mmol/L) relaxant effect (Figure 6).
Ethanol, the vehicle used to dissolve forskolin, roli-
pram, betahistine, RMH, and L69, did not have a signif-
icant relaxant effect at the concentrations used (data not
shown).
Effect of 5-HT and Histamine Agonists on
Intracellular cAMP Concentration
To analyze the involvement of the cAMP pathway in the
effects induced by the activation of some 5-HT and his-
tamine receptors in HUA smooth muscle, we examined
the effects of some agonists of these receptors on the intra-
cellular cAMP levels ([cAMP]i).
As shown in Figure 7, the basal level of [cAMP]i was
51.4 + 8.1 pmol/mg and forskolin (10 mmol/L), an
adenylate cyclase activator, significantly increased this
level (P < .05).
The 5-HT1B/D agonist, supposed to inhibit adenylate
cyclase, did not significantly modify the basal [cAMP]i.
The agonist of 5-HT7, supposed to activate the adeny-
late cyclase, did not significantly increase the [cAMP]i,
(P ¼ .09; Figure 7).
Concerning the histamine receptors, the agonists
of H2 and H3 receptors increased the basal [cAMP]i
(P < 0.05). However, the agonist of H4 did not induce
a significant increase in [cAMP]i (Figure 7).
Ethanol, the vehicle used to dissolve forskolin, AS19,
RMH, and L69, did not have a significant relaxant effect
at the concentrations used (data not shown).
DISCUSSION
The tone of the umbilical artery is essential for fetal
growth and development. Histamine and 5-HT are 2 key
regulators of human umbilical artery (HUA) contractility
and its effects can be mediated by the activation of differ-
ent receptor types. Several authors described that increase
of vascular resistance in some pathologies, as preeclamp-
sia, is associated with increases in the release of histamine
and 5-HT and in the sensitivity of the HUA to these
Figure 5. Contractile effect of different histamine receptor agonists.
The contractile effect (mg) induced by histamine (His; 10 mmol/L),
betahistine (BHI, H1 agonist; 1 mmol/L), dimaprit (DMP, H2
agonist; 100 mmol/L), RMH (H3 agonist; 0.1 mmol/L), 4-MH (H4
agonist; 0.1 mmol/L), and histamine in combination with cimetidine
(Cim, H2 antagonist) is indicated. The bars represent the mean and
the lines the SEM of the number of experiments indicated near the
bar. Different letters indicated significant differences and when bars
do not share the same letter this means that there are significant
differences (P < .05, one-way ANOVA with Tukey post hoc test)
between the effects.
Figure 6. Relaxant effect of H3 and H4 receptor activation.
Relaxant effects of RMH (H3 agonist; 0.1 mmol/L) and 4-MH (H4
agonist; 0.1 mmol/L) on betahistine (BHI, H1 agonist; 1 mmol/L)
contracted human umbilical artery (HUA) in presence and absence of
adenylate cyclase activation by forskolin (FSK, 0.1 mmol/L). The bars
represent the mean and the lines the SEM of the number of
experiments indicated near the bar. Different letters indicated
significant differences and when bars do not share the same letter
this means that there are significant differences (P < .05, one-way
ANOVA with Tukey post hoc test) between the effects.
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mediators.9-12 Thus, further knowledge about the 5-HT
and histamine receptors involved in the regulation of
HUA contractility could open new perspectives useful for
the treatment of some diseases.
In the current study, we analyzed the expression of
different receptor subtypes of these signaling molecules
and their role regulating denuded HUA contractility.
According to the literature, the contractile effect of
5-HT in denuded HUA can be due to the activation of
3 receptors subtypes12,17,34: 5-HT1B and 5-HT1D whose
activation inhibits adenylate cyclase; and 5-HT2A which
activation increases inositol 1,4,5-triphosphate (IP3) lev-
els. As suggested by other authors, some of these receptors
are important in the regulation of HUA tone.3,12,17 An
increase in the sensibility to 5-HT in HUA arteries
obtained from women with pregnancy-induced hyper-
tension was observed,35 suggesting an involvement of
these receptors in this pathology. Our data show that
5-HT1B, 5-HT1D, and 5-HT2A receptors are expressed
in HUA smooth muscle. Lovren et al already showed that
5-HT1B and 5-HT2A, but in contrast with our results,
these authors did not find expression of 5-HT1D in
HUA.17 5-HT and the selective 5-HT2A agonist
(AMHT) induced a similar degree of contractility and the
5-HT2A antagonist (ketanserin) almost completely
relaxed the HUA rings contracted by 5-HT. In agree-
ment with other authors,3,12,17 our data suggest that the
key receptor eliciting the HUA contractile response
induced by serotonin is 5-HT2A. However, L69, a
5-HT1B/1D agonist, also induces contraction of HUA,
even if these effects are dual because in most of the arteries
it induced a small contractile effect (167.7 + 22.9 mg)
but in some cases a bigger contraction (around 1000
mg) was obtained. Other authors showed that sumatrip-
tan and 5-nonyloxytryptamine (5-HT1B and 5-HT1D
agonists) do not always contract the HUA. They showed
that only if the HUA is treated with a contractile
subthreshold concentration of KCl or some agonists
(prostaglandin F2a, U44069, histamine or 5-HT) then the
sumatriptan and 5-nonyloxytryptamine contracted all
HUA rings.17 However, in our case, the variability does
not have relationship with the test response to 5-HT (per-
formed to asses the viability of the rings). Other authors
observed that 5-HT1B/1D receptor activation every time
induces a consistent contraction of HUA.12 Verheggen
et al, working with human occipital artery, demonstrated
that the expression of these receptors is variable, because
from 18 arteries analyzed, 3 arteries did not express the
5-HT1B receptors and 4 did not express the 5-HT1D
receptor.36 On the contrary, we detect expression of
these receptors in 5 HUA smooth muscle layers analyzed.
These receptors are negatively coupled with adenylate
cyclase, which means that their activation can decrease
the cAMP intracellular level. However, in agreement
with other authors,15,16 our data did not show this,
because the agonists of these receptors did not decrease
the basal [cAMP]i. Thus, even if the 5-HT2A receptors are
mainly responsible for 5-HT contractile effect of HUA,
5-HT1B and/or 5-HT1D are also involved, even if their
contribution appears to be variable. Similar results were
observed in human pulmonary37 and occipital36 arteries.
Contrary to the 5-HT receptors whose activation is
coupled to induce vascular contractility, the 5-HT7
receptors can mediate vascular relaxation because they are
positively coupled to adenylate cyclase. These receptors
were found to be expressed in different human arteries
such as pulmonary and coronary arteries and aorta.14,38
Now, our data demonstrate that there is expression of
5-HT7 receptors in HUA smooth muscle. In addition,
the 5-HT7 agonist (AS19) weakly relaxed (11.6% +
2.0%) the HUA rings contracted by AMHT and this
effect was similar to that induced by the adenylate cyclase
activator forskolin. Previously, Jahnichen et al observed
that 5-HT7 receptor activation induces endothelium-
independent relaxation of pig pulmonary artery.18 We
Figure 7. Effects of histamine and 5-HT receptor activation and
forskolin on cyclic adenosine monophosphate (cAMP) intracellular
levels. The cAMP intracellular level was analyzed in human umbilical
artery (HUA) layers of HUA in absence (control) or presence of
forskolin (FSK; 10 mmol/L), L69 (agonist 5-HT1B/1D, 1 mmol/L),
AS19 (agonist 5-HT7, 1 mmol/L), dimaprit (DMP, agonist H2;
100 mmol/L), RMH (agonist H3, 0.1 mmol/L), and 4-MH (agonist
H4, 0.1 mmol/L). The effects are expressed in pmol per g of cAMP.
The bars indicate the mean and the lines the SEM of the number of
preparations indicated near the bars. Statistical significant differences
versus control effect was performed using one-way ANOVA with
Dunnet’s post hoc test (*P < .05).
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also performed some experiments using a PDE4 inhibitor
to confirm the role of these receptors. As expected, the
forskolin effect is increased when PDE4 is inhibited by
rolipram, but the relaxant effect induced by AS19 was not
significantly increased in the presence of rolipram. How-
ever, the activation of 5-HT7 receptors did not increase
induce a significant raise on cAMP. Nonetheless, for the
first time, we show the expression of these receptors in
HUA smooth muscle. The activation of these receptors
induces a weak relaxing effect, suggesting that these
receptors have a role in the regulation of the HUA con-
tractility and could constitute a therapeutic target for the
treatment of preeclampsia or hypertension in pregnancy
to elude limitation in blood circulation between the
mother and fetus.
Histamine has been shown to exert both contractile
and dilating effects on different vascular smooth muscles.
Usually, histamine induces contraction of large vessels
and dilatation of small vessels.20 The involvement of dif-
ferent histamine receptors on this effect was analyzed
using specific agonists and antagonists of several histamine
receptor types. Our data show that only the H1-receptor
agonist induces a significant contractile effect, which is
higher than the contractile effect induced by histamine
itself. These data suggest either that histamine is less selec-
tive for H1 receptor or that histamine effect is the conse-
quence of the activation of different receptors inducing
opposite effects. Histamine-induced contraction was
almost completely relaxed by pyrilamine, a H1 antagonist,
suggesting that the contractile effect is due to the activa-
tion of this receptor. The activation of H1 receptor
increases IP3 and intracellular calcium levels.
39 The
importance of the H1 receptor to trigger vascular contrac-
tility in some arteries is also supported by other authors
working with human radial and coronary arteries.40,41
In agreement with other studies,42 our data indicate
that H2 receptors are also expressed in HUA smooth mus-
cle. The activation of these receptors stimulates adenylate
cyclase, increasing cAMP intracellular levels,20 a nucleo-
tide which is related to artery vasorelaxation.5 The activa-
tion of these receptors induced relaxation (25.3% +
2.0%) of the HUA contracted by betahistine (agonist
H1). Furthermore, the inhibition of these receptors
induced a small increase of histamine-induced contrac-
tions. Besides, the effect of histamine and cimetidine
applied in combination was not significantly different
than that induced by the H1 agonist BHI. Daneshmand
et al had also reported that stimulation of H2 receptor
causes vasodilatation of human internal thoracic and radial
arteries.40 Moreover, Martinez et al showed that the
vasodilatation of human dorsal penile artery induced by
histamine seems to be mainly mediated by H2 receptors.
43
Our results demonstrate that activation of H2 significantly
increases [cAMP]i in HUA smooth muscle. The physio-
logical implications of the H2-induced relaxation can be
large, because Suzuki et al observed reduction in this
relaxation in preeclampsia and suggested that this is due
to the attenuation of the relaxing action of cAMP in these
conditions.44
Finally, our results demonstrate that H3 and H4
receptors are also expressed in HUA smooth muscle. The
agonists for H3 and H4 receptors, RMH and 4-MH,
respectively, did not induce any contractile effect in
HUA. However, RMH and 4-MH did not significantly
relax the contraction induced by betahistine. The signal
transduction pathways involved in H3 receptor activation
remain largely subject to speculation. Studies performed
in nervous and heart cells suggested that this receptor is
coupled to Gi or G0
20. However, some authors have
failed to observe an inhibition of adenylate cyclase activity
in different tissues and cells.22,45 Other authors demon-
strated that activation of this receptor relaxes rat mesen-
teric24 and horse penile dorsal arteries,23 an effect which
is contradictory with the activation of Gi protein which
will lead to a decrease of cAMP levels. Studies performed
in nonvascular cells suggested that alternative pathways
can be triggered after the activation of the H3 receptor,
such as inhibition of phospholipase C45 or activation of
the MAPK-PLA2 cascade.
46 Our data show, for the first
time, that the activation of the H3 receptor induces signif-
icant increase of [cAMP]i. The H3 agonist significantly
increased the relaxing effect induced by low concentra-
tions of forskolin (0.1 mmol/L), a cAMP elevating agent.
Forskolin is a potent vasodilator of the histamine-con-
tracted HUA5 and also relaxes betahistine-contracted
arteries. These data suggest that the H3 receptors can
induce relaxant effects through the cAMP pathway. Thus
H3 activation does not activate a Gi protein, as indicated
by other authors. Concerning the H4 receptors, it was
reported that the activation of these receptors causes
either mobilization of intracellular calcium or inhibition
of the adenylate cyclase activity.25 Our data show that the
activation of H4 receptor neither modulates the cAMP
levels nor the HUA tone, even in presence of low con-
centrations of forskolin.
In conclusion, 5-HT and histamine can regulate
HUA tone. 5-HT-induced contractions are mediated
by the activation of 5-HT2A receptors and partially by the
activation of 5-HT1B/1D receptors. The activation of 5-
HT7 induces relaxation of contracted HUA. Concerning
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the histamine receptors, H1 receptor activation induces
contraction and H2 and H3 receptors activation mediates
HUA relaxation through the increase of cAMP intracel-
lular levels, although the pathway involved in the H3 acti-
vation needs to be further investigated. These data suggest
that histamine and serotonin receptors are potential tar-
gets to develop a future therapeutic strategy for the treat-
ment of some diseases as preeclampsia.
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